The most successful high-tech start-up companies are those that combine cutting-edge science with a high level of business acumen—companies that know the value of their technology and can exploit it to open up future business opportunities.

In few areas can this be more true than in the field of biotechnology, particularly in this post-genomic era. The Astellas Group's strength in adding to corporate value is in our ability to correlate productively all the relevant information we have available throughout our worldwide organization, and to bring this information together with the capital, support resources and opportunities to expedite success.

Our goal is to be, not just an investor, but a productive partner working for the success of the company.